JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (1988) 119, 233-241       DOI: 10.1677/joe.0.1190233
© 1988 Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Farnworth, P. G.
Right arrow Articles by Burger, H. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Farnworth, P. G.
Right arrow Articles by Burger, H. G.

Effects of 31 kDa bovine inhibin on FSH and LH in rat pituitary cells in vitro: antagonism of gonadotrophin-releasing hormone agonists

P. G. Farnworth, D. M. Robertson, D. M. de Kretser and H. G. Burger

The effects of 31 kDa bovine inhibin on the release of FSH and LH stimulated by gonadotrophin-releasing hormone (GnRH) or its agonist analogue buserelin have been studied using 5-day-old cultures of pituitary cells prepared from adult male Sprague–Dawley rats. Exposure of cultures to increasing concentrations of inhibin for 3 days before and during a 4-h stimulation with GnRH resulted in the progressive suppression of both basal and stimulated gonadotrophin release. At the highest inhibin concentrations FSH release was abolished (inhibin median inhibitory concentration (IC50) = 0·15 U/ml) whereas LH release was suppressed by 75% (IC50 = 0·93 U/ml). To correct for the reduced size of the FSH pool resulting from inhibin pretreatment, the amount of FSH or LH released by an agonist was expressed as a proportion of the total hormone available for release in each case. Following this adjustment, concentrations of inhibin producing maximal effects increased the GnRH median effective concentration for FSH release 4·1-fold and that for LH release 2·2-fold, with inhibin IC50 values of 0·45 and 0·32 U/ml respectively. Inhibin also suppressed the maximum proportion of both FSH and LH that excess GnRH released in 4 h by 36%, with IC50 values of 0·53 and 0·76 U/ml respectively. These effects were not changed by reduction of the inhibin pretreatment period from 3 days to 1 day or by exclusion of inhibin during the stimulation period. After a 3-day pretreatment, inhibin inhibited gonadotrophin release by buserelin less effectively than that by GnRH, but the pattern of antagonism was the same.

The results show that purified bovine inhibin antagonizes the release of both FSH and LH stimulated by either GnRH or buserelin in vitro by reducing the apparent potency of GnRH agonists and by decreasing the proportion of total available gonadotrophin that can be released by an excess of GnRH agonist. Higher concentrations of inhibin are required for these common actions against stimulated release of FSH and LH than for the inhibition of FSH tonic synthesis/basal release, indicating one or more secondary sites of inhibin action in addition to its primary selective action to suppress the constitutive synthesis of FSH.

J. Endocr. (1988) 119, 233–241




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
D. M. Robertson, G. E. Hale, D. Jolley, I. S. Fraser, C. L. Hughes, and H. G. Burger
Interrelationships between Ovarian and Pituitary Hormones in Ovulatory Menstrual Cycles across Reproductive Age
J. Clin. Endocrinol. Metab., January 1, 2009; 94(1): 138 - 144.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
A. Gordon, J. C Garrido-Gracia, R. Aguilar, C. Bellido, J. A G. Velasco, Y. Millan, M. Tena-Sempere, J. Martin de las Mulas, and J. E Sanchez-Criado
The ovary-mediated FSH attenuation of the LH surge in the rat involves a decreased gonadotroph progesterone receptor (PR) action but not PR expression
J. Endocrinol., March 1, 2008; 196(3): 583 - 592.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the Society for Endocrinology.